1-6 of 6
Christopher Sweeney
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Phase I Study of Niraparib in Combination with Radium-223 for the Treatment of Metastatic Castrate-Resistant Prostate Cancer

Zachary Quinn, Benjamin Leiby, Guru Sonpavde, Atish D. Choudhury, Christopher Sweeney, David Einstein, Russell Szmulewitz, Oliver Sartor, Karen Knudsen, Eddy Shih-Hsin Yang, Wm. Kevin Kelly
Journal: Clinical Cancer Research
Clin Cancer Res (2023) 29 (1): 50–59.
https://doi.org/10.1158/1078-0432.CCR-22-2526
Published: 04 January 2023
View article titled, Phase I Study of Niraparib in Combination with Radium-223 for the Treatment of Metastatic Castrate-Resistant Prostate Cancer
Open the PDF for Phase I Study of Niraparib in Combination with Radium-223 for the Treatment of Metastatic Castrate-Resistant Prostate Cancer in another window
Includes: Supplementary data
Journal Articles

SPINK1 Protein Expression and Prostate Cancer Progression

Richard Flavin, Andreas Pettersson, Whitney K. Hendrickson, Michelangelo Fiorentino, Stephen Finn, Lauren Kunz, Gregory L. Judson, Rosina Lis, Dyane Bailey, Christopher Fiore, Elizabeth Nuttall, Neil E. Martin, Edward Stack, Kathryn L. Penney, Jennifer R. Rider, Jennifer Sinnott, Christopher Sweeney, Howard D. Sesso, Katja Fall, Edward Giovannucci, Philip Kantoff, Meir Stampfer, Massimo Loda, Lorelei A. Mucci
Journal: Clinical Cancer Research
Clin Cancer Res (2014) 20 (18): 4904–4911.
https://doi.org/10.1158/1078-0432.CCR-13-1341
Published: 14 September 2014
View article titled, SPINK1 Protein Expression and Prostate Cancer Progression
Open the PDF for SPINK1 Protein Expression and Prostate Cancer Progression in another window
Journal Articles

Phase II Clinical Trial Design: Methods in Translational Research from the Genitourinary Committee at the Eastern Cooperative Oncology Group

Robert Gray, Judith Manola, Scott Saxman, John Wright, Jan Dutcher, Michael Atkins, Michael Carducci, William See, Christopher Sweeney, Glenn Liu, Mark Stein, Robert Dreicer, George Wilding, Robert S. DiPaola
Journal: Clinical Cancer Research
Clin Cancer Res (2006) 12 (7): 1966–1969.
https://doi.org/10.1158/1078-0432.CCR-05-1136
Published: 11 April 2006
View article titled, Phase II Clinical Trial Design: Methods in Translational Research from the Genitourinary Committee at the Eastern Cooperative Oncology Group
Open the PDF for Phase II Clinical Trial Design: Methods in Translational Research from the Genitourinary Committee at the Eastern Cooperative Oncology Group in another window
Journal Articles

A Phase II Multicenter, Randomized, Double-Blind, Safety Trial Assessing the Pharmacokinetics, Pharmacodynamics, and Efficacy of Oral 2-Methoxyestradiol Capsules in Hormone-Refractory Prostate Cancer

Christopher Sweeney, Glenn Liu, Constantin Yiannoutsos, Jill Kolesar, Dorothea Horvath, Mary Jane Staab, Karen Fife, Victoria Armstrong, Anthony Treston, Carolyn Sidor, George Wilding
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (18): 6625–6633.
https://doi.org/10.1158/1078-0432.CCR-05-0440
Published: 15 September 2005
View article titled, A Phase II Multicenter, Randomized, Double-Blind, Safety Trial Assessing the Pharmacokinetics, Pharmacodynamics, and Efficacy of Oral 2-Methoxyestradiol Capsules in Hormone-Refractory Prostate Cancer
Open the PDF for A Phase II Multicenter, Randomized, Double-Blind, Safety Trial Assessing the Pharmacokinetics, Pharmacodynamics, and Efficacy of Oral 2-Methoxyestradiol Capsules in Hormone-Refractory Prostate Cancer in another window
Journal Articles

Nuclear Factor-κB Is Constitutively Activated in Prostate Cancer In vitro and Is Overexpressed in Prostatic Intraepithelial Neoplasia and Adenocarcinoma of the Prostate

Christopher Sweeney, Lang Li, Rajasubramaniam Shanmugam, Poornima Bhat-Nakshatri, Vetrichelvan Jayaprakasan, Lee Ann Baldridge, Thomas Gardner, Martin Smith, Harikrishna Nakshatri, Liang Cheng
Journal: Clinical Cancer Research
Clin Cancer Res (2004) 10 (16): 5501–5507.
https://doi.org/10.1158/1078-0432.CCR-0571-03
Published: 24 August 2004
View article titled, Nuclear Factor-κB Is Constitutively Activated in Prostate Cancer <em>In vitro</em> and Is Overexpressed in Prostatic Intraepithelial Neoplasia and Adenocarcinoma of the Prostate
Open the PDF for Nuclear Factor-κB Is Constitutively Activated in Prostate Cancer <em>In vitro</em> and Is Overexpressed in Prostatic Intraepithelial Neoplasia and Adenocarcinoma of the Prostate in another window
Journal Articles

A Phase I Trial of a Potent P-Glycoprotein Inhibitor, Zosuquidar Trihydrochloride (LY335979), Administered Intravenously in Combination with Doxorubicin in Patients with Advanced Malignancy

Alan Sandler, Michael Gordon, Dinesh P. de Alwis, Isabelle Pouliquen, Lisa Green, Phil Marder, Ajai Chaudhary, Karen Fife, Linda Battiato, Christopher Sweeney, Christopher Jordan, Michael Burgess, Christopher A. Slapak
Journal: Clinical Cancer Research
Clin Cancer Res (2004) 10 (10): 3265–3272.
https://doi.org/10.1158/1078-0432.CCR-03-0644
Published: 24 May 2004
View article titled, A Phase I Trial of a Potent P-Glycoprotein Inhibitor, Zosuquidar Trihydrochloride (LY335979), Administered Intravenously in Combination with Doxorubicin in Patients with Advanced Malignancy
Open the PDF for A Phase I Trial of a Potent P-Glycoprotein Inhibitor, Zosuquidar Trihydrochloride (LY335979), Administered Intravenously in Combination with Doxorubicin in Patients with Advanced Malignancy in another window